[1]
Bahamdain, F.O. 2022. Retracted: Effect of dolutegravir on plasma glucose among human immunodeficiency virus patients in a community health center setting. International Journal Of Community Medicine And Public Health. 9, 3 (Feb. 2022), 1178–1182. DOI:https://doi.org/10.18203/2394-6040.ijcmph20220673.